MedPath

Effects of vitamin E in the treatment of dengue infection in childre

Phase 4
Conditions
Dengue Infection
Registration Number
SLCTR/2015/012
Lead Sponsor
Department of Paediatrics, Faculty of Medicine, University of Colombo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow up complete
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1. Admission to the study setting (Ward 1, LRH) within 84 hours of the onset of fever

2. Clinical diagnosis of dengue infection (clinical criteria of the National Guidelines for Management of Dengue, Ministry of Health, Sri Lanka)

Exclusion Criteria

1. Any underlying chronic disease (e.g. cardiac disease, renal disease, hepatic disease and muscular disorders)

2. Children on any long term medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantitative outcomes<br>1.1.Platelet count<br>1.2.Lowest platelet count<br>1.3.Haematocrit<br>1.4.Highest haematocrit<br>1.5.Duration of fever<br>1.6.Serum albumin<br><br> [Quantitative outcomes<br>1. On admission, day 3 and discharge<br>2. From time of admission to time of discharge<br><br>All other outcomes will be assessed on day 1, day 3, day 5 and day 7 of illness]<br>Qualitative outcomes<br>1.1.Entry into critical phase<br>1.2.Use of dextran<br>1.3.Presence of effusions on ultra sound scan<br>1.4.Need for catheterization [ ]<br>
Secondary Outcome Measures
NameTimeMethod
one<br> [None<br>]<br>
© Copyright 2025. All Rights Reserved by MedPath